Cancer Therapy Powered By You
®
Personalized immunotherapy designed to empower your immune system to fight cancer
What If
There was a therapy that could attack cancer throughout
The Entire Body?
At Syncromune, we are working relentlessly to achieve this goal to transform the way cancer is treated and help patients
Patient Resources
The following are additional resources to learn more about immunotherapy and SYNC-T’s initial indications: metastatic prostate cancer, metastatic breast cancer, and metastatic non-small cell lung cancer.
Investigational Clinical Trials for Solid Tumors
We’re committed to our mission of finding new treatments that may help improve the lives of patients with cancer. Our clinical trials for solid tumor cancers study combination investigational medications and medical devices. We are performing these trials to assess if the therapy can help to treat advanced cancer.
STATUS
TRIAL NAME
TRIAL REFERENCE NUMBER
Recruiting
Phase 1 Investigator Initiated Trial of SYNC-T SV-102 Immunotherapy for Advanced/​Metastatic Castration-Resistant Prostate Cancer
Locations
Hospital Diomed
Mexico City, MX
Condition
Metastatic Castration-Resistant Prostate Cancer
STATUS
TRIAL NAME
TRIAL REFERENCE NUMBER
Recruiting
Phase 1 Investigator Initiated Trial of SYNC-T SV-101 Immunotherapy for Patients With Advanced / Metastatic Breast Cancer
STATUS
TRIAL NAME
TRIAL REFERENCE NUMBER
Recruiting
Phase 1 Investigator Initiated Trial of SYNC-T SV-101 Immunotherapy for Patients With Advanced / Metastatic Non-Small Cell Lung Cancer
Disclaimers: The content on this website is intended for US healthcare professionals only. The compounds and their uses mentioned on this website are investigational and have not been determined safe and effective by the US Food and Drug Administration.